Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
153 results:

  • 1. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
    Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
    Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
    Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of systemic inflammation and frailty on survival in elderly cancer patients: Results from the INSCOC study.
    Zhang Q; Wang Z; Song M; Liu T; Ding J; Deng L; Zhang X; Qian L; Ge Y; Xie H; Ruan G; Song C; Yao Q; Xu H; Ju H; Shi H
    Front Immunol; 2023; 14():936904. PubMed ID: 36891320
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined PD-1, BRAF and MEK inhibition in BRAF
    Tian J; Chen JH; Chao SX; Pelka K; Giannakis M; Hess J; Burke K; Jorgji V; Sindurakar P; Braverman J; Mehta A; Oka T; Huang M; Lieb D; Spurrell M; Allen JN; Abrams TA; Clark JW; Enzinger AC; Enzinger PC; Klempner SJ; McCleary NJ; Meyerhardt JA; Ryan DP; Yurgelun MB; Kanter K; Van Seventer EE; Baiev I; Chi G; Jarnagin J; Bradford WB; Wong E; Michel AG; Fetter IJ; Siravegna G; Gemma AJ; Sharpe A; Demehri S; Leary R; Campbell CD; Yilmaz O; Getz GA; Parikh AR; Hacohen N; Corcoran RB
    Nat Med; 2023 Feb; 29(2):458-466. PubMed ID: 36702949
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials.
    Diefenhardt M; Fleischmann M; Martin D; Hofheinz RD; Piso P; Germer CT; Hambsch P; Grützmann R; Kirste S; Schlenska-Lange A; Ghadimi M; Rödel C; Fokas E;
    Radiother Oncol; 2023 Feb; 179():109455. PubMed ID: 36572280
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
    Paszt A; Ottlakan A; Abraham S; Simonka Z; Vas M; Maraz A; Szepes Z; Tiszlavicz L; Nyari T; Olah J; Lazar G
    Pathol Oncol Res; 2022; 28():1610722. PubMed ID: 36567978
    [No Abstract]    [Full Text] [Related]  

  • 9. Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic colorectal cancer: PLATFORM-B Study.
    Vidal J; Fernández-Rodríguez MC; Casadevall D; García-Alfonso P; Páez D; Guix M; Alonso V; Cano MT; Santos C; Durán G; Elez E; Manzano JL; Garcia-Carbonero R; Ferreiro R; Losa F; Pineda E; Sastre J; Rivera F; Bellosillo B; Tabernero J; Aranda E; Salazar R; Montagut C;
    Clin Cancer Res; 2023 Jan; 29(2):379-388. PubMed ID: 36074154
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Applicability of five nutritional screening tools in Chinese patients undergoing colorectal cancer surgery: a cross-sectional study.
    Xie B; Sun Y; Sun J; Deng T; Jin B; Gao J
    BMJ Open; 2022 May; 12(5):e057765. PubMed ID: 35623749
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
    Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
    Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SPATA18 Expression Predicts Favorable clinical outcome in colorectal cancer.
    Sugimura-Nagata A; Koshino A; Nagao K; Nagano A; Komura M; Ueki A; Ebi M; Ogasawara N; Tsuzuki T; Kasai K; Takahashi S; Kasugai K; Inaguma S
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269894
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Oncotype DX testing does not affect clinical practice in stage IIa colon cancer.
    Allar BG; Messaris E; Poylin VY; Schlechter BL; Cataldo TE
    Med Oncol; 2022 Feb; 39(5):59. PubMed ID: 35150339
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
    Nguyen HG; Lundström O; Blank A; Dawson H; Lugli A; Anisimova M; Zlobec I
    Mod Pathol; 2022 Feb; 35(2):240-248. PubMed ID: 34475526
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8
    Munari E; Marconi M; Querzoli G; Lunardi G; Bertoglio P; Ciompi F; Tosadori A; Eccher A; Tumino N; Quatrini L; Vacca P; Rossi G; Cavazza A; Martignoni G; Brunelli M; Netto GJ; Moretta L; Zamboni G; Bogina G
    Front Immunol; 2021; 12():680973. PubMed ID: 34122444
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anaemia and its impact on colorectal cancer patients: how can we better optimize surgical outcomes?
    Roberts V; Deftereos I; Mahbub B; Simons K; Faragher I; Chan STF; Yeung JM
    ANZ J Surg; 2021 May; 91(5):E280-E285. PubMed ID: 33851493
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Stathmin expression in metastatic colorectal cancer.
    Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Are C
    J Surg Oncol; 2021 May; 123(8):1764-1772. PubMed ID: 33765336
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Perineal hernia repair after abdominoperineal rectal excision with prosthetic mesh-a single surgeon experience.
    Morales-Cruz M; Oliveira-Cunha M; Chaudhri S
    Colorectal Dis; 2021 Jun; 23(6):1569-1572. PubMed ID: 33567120
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract] [Full Text] [Related]  


    of 8.